Literature DB >> 33985904

The new legal framework for minimally manipulated cells expands the possibilities for cell therapy in Russia.

Olga A Krasilnikova1, Ilya D Klabukov2, Denis S Baranovskii3, Peter V Shegay1, Andrey D Kaprin1.   

Abstract

Year:  2021        PMID： 33985904     DOI： 10.1016/j.jcyt.2021.03.007

Source DB:  PubMed          Journal:  Cytotherapy        ISSN： 1465-3249            Impact factor:   5.414


× No keyword cloud information.
  1 in total

1.  Minimally Manipulated Bone Marrow-Derived Cells Can Be Used for Tissue Engineering In Situ and Simultaneous Formation of Personalized Tissue Models.

Authors:  D S Baranovskii; B G Akhmedov; A G Demchenko; M E Krasheninnikov; M V Balyasin; O Yu Pavlova; N S Serova; O A Krasil'nikova; P V Shegai; A D Kaprin; I D Klabukov
Journal:  Bull Exp Biol Med       Date:  2022-05-27       Impact factor: 0.804
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.